MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2017-09-14 for TISSUGLU SURGICAL ADHESIVE TG100US manufactured by Cohera Medical Inc.
[86244842]
It was reported to the company by a healthcare professional that a patient underwent an abdominoplasty surgery using tissuglu surgical adhesive in conjunction with standard of care on (b)(6) 2017. On (b)(6) 2017, the surgeon informed cohera that she performed an irrigation and debridement procedure to address a wound located on the patient's reconstructed umbilical skin. On (b)(6) 2017, additional information was provided to the company that allegedly the patient continued to leak blood and pieces of a foreign body (assumed to be remnants of cured tissuglu? Surgical adhesive) through her suture line. The patient appears to have experienced an instance of tissuglu extrusion. The reported opening on the suture line and extrusion of tissuglu? Surgical adhesive fragments is consistent with known potential complications associated with abdominoplasty surgeries and is described as a precaution in the tissuglu surgical adhesive directions for use (dfu-100-0001): "consideration should be taken in the use of tissuglu? , as there is a possibility that cured tissuglu? May be extruded similar to suture extrusion. The patient is currently being treated for minor complications associated with the additional surgical procedure. It is not anticipated that the existence or expulsion of tissuglu will present any adverse reaction, infection, or other health consequence associated with the expulsion of the tissuglu fragments.
Patient Sequence No: 1, Text Type: D, B5
[110479701]
According to the physician the patient identified in this report has allegedly had additional cured adhesive extrusion from the suture line which occurred between september (b)(6) 2017.
Patient Sequence No: 1, Text Type: N, H10
[112630232]
On may 8, 2018 it was reported that the patient has allegedly continued to leak fluid and minute pieces of residual glue from the incision line. The patient and physician have planned to perform a revision to remove the residual adhesive from the patient.
Patient Sequence No: 1, Text Type: N, H10
Report Number | 3012970114-2017-00003 |
MDR Report Key | 6866959 |
Report Source | COMPANY REPRESENTATIVE |
Date Received | 2017-09-14 |
Date of Report | 2017-09-14 |
Date of Event | 2017-08-16 |
Date Mfgr Received | 2017-08-21 |
Device Manufacturer Date | 2016-05-02 |
Date Added to Maude | 2017-09-14 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MR CHRIS FERGUSON |
Manufacturer Street | 227 FAYETTEVILLE ST SUITE 900 |
Manufacturer City | RALEIGH NC 27601 |
Manufacturer Country | US |
Manufacturer Postal | 27601 |
Manufacturer Phone | 9842220391 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | TISSUGLU SURGICAL ADHESIVE |
Generic Name | TISSUGLU |
Product Code | PJK |
Date Received | 2017-09-14 |
Model Number | TG100US |
Catalog Number | TG100US |
Lot Number | CM0340 |
Device Expiration Date | 2018-04-30 |
Operator | HEALTH PROFESSIONAL |
Device Availability | N |
Device Age | DA |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | COHERA MEDICAL INC |
Manufacturer Address | 227 FAYETTEVILLE ST SUITE 900 RALEIGH NC 27601 US 27601 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Required No Informationntervention | 2017-09-14 |